AIMS The ultrasound assessment of bladder wall thickness (BWT) and intravesical prostatic
protrusion (IPP) have emerged as a non‐invasive, inexpensive, time‐saving alternatives to …

Aims We prospectively investigated the effect of dutasteride on clinical and urodynamic
parameters in patients with benign prostatic enlargement (BPE). Materials and Methods A …

Purpose To identify the clinical factors resulting in the failure of dutasteride add-on treatment
to alpha-adrenergic antagonist for patients with lower urinary tract symptoms and benign …

Objective To investigate the value of anatomic and blood-flow measurements of the prostate
via ultrasound in identifying medical treatment response of patients with lower urinary tract …

Aims We investigated predicting factors for the therapeutic effects of dutasteride in patients
with lower urinary tract symptoms (LUTS) due to benign prostatic enlargement (BPE) based …

Aims: The purpose of this study is to examine how different doses of dutasteride (0.5 mg) in
combination with tamsulosin affect the outcome of treatment of benign prostatic enlargement …

Purpose To investigate the efficacy of dutasteride add-on treatment to tadalafil in patients
with lower urinary tract symptoms (LUTS) suggestive of benign prostatic enlargement (BPE) …

Objective To evaluate the role of intravesical prostatic protrusion (IPP) as a predictive factor
for adverse clinical outcomes in patients treated with dutasteride for lower urinary tract …

Objectives To evaluate the correlation of clinical and urodynamic parameters with bladder
vascular resistance before and after dutasteride treatment in patients with lower urinary tract …

Background To investigate the efficacy of tamsulosin in patients with lower urinary tract
symptoms (LUTS) and benign prostatic enlargement (BPE) with intravesical prostatic …